Evaluation of the concept of 'hypoxic fraction' as a descriptor of tumor oxygenation status

Advances in Experimental Medicine and Biology

Volumn 411, Issue , 1997, Pages 215-225

  Evans, S M ^a   Jenkins, W T ^a   Shapiro, M ^a   Koch, C J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CANCER; CANCER RADIOTHERAPY; HYPOXIA; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; RAT; TISSUE OXYGENATION; TUMOR; TUMOR BLOOD FLOW;

ANIMALIA;

EID: 0030854534     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5865-1_26     Document Type: Article

References (24)

1. Hockel, M., Knoop, C., Schlenger, K., Vordran, B., Baussmann, E., Mitze, M., Knapstein, P. G., and Vaupel, P. Intratumor pO2 predicts survival in advanced cancer of the uterine cervix. Radiotherapy and Oncology, 26:45-50. 1993.
2. Gatenby, R. A., Kessler, H. B., Rosenblum. J. S., Coia, L. R., Moldofsky, P. J., Hartz, W. H., and Broder, G. J. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of therapy. Int. J. Radiat. Oncol. Biol. Phys., 14:831-838, 1988.
3. Kallinowski, F., and Buhr, H. J. Can the oxygenation status of rectal carcinomas be improved by hyperoxia? pp. 291-296, 1995. In: Tumor Oxygenation. Eds. Vaupel, Kelleher, Gunderoth. Gustav Fischer Verlag, Stuttgart, 1995.
4. Moulder, J. E., and Rockwell, S. C. Hypoxic fractions of solid tumors: experimental techniques, methods of analysis and a survey of existing data. Int. J. Radiat. Oncol. Biol. Phys., 10:695-712, 1984.
5. Horsman, M. R., Khalil, A. A., Nordsmark, M., Siemann, D. W., Hill S. A.,Lynch, E. M., Chaplin, D. J., Stern, S., Thamas, C. D., Guichard, M., Grau, C., and Overgaard, J. The use of oxygen electrodes to predict radiobiological hypoxia in tumors, pp. 49-58, In: Tumor Oxygenation. Eds. Vaupel, Kelleher, Gunderoth. Gustav Fischer Verlag, Stuttgart, 1995.
6. Rockwell, S., Moulder, J. E., and Douglas, F. M. Tumor-to-tumor variability in the hypoxic fractions of experimental rodent tumors. Radiotherapy and Oncology, 2:57-64, 1984.
7. Evans, S. M., Joiner, B. J., Jenkins, W. T., Laughlin, K. M., Lord, E. M., and Koch, C. J. Identification of hypoxia in cells and tissues of epigastric 9L rat tumours using EF5. Br. J. Cancer, 72: 875-882, 1995.
8. Thomlinson, R. H., and Gray, L. H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br. J. Cancer, 9:539-579, 1955.
9. Woods, M. R., Lord, E. M., and Koch, C. J. Prediction of hypoxic radioresistance by monoclonal antibody reactive with 2-nitroimidazole adducts. Int. J. Radiat. Oncol. Biol. Phys., 34: 93-101, 1996.
10. Leith, J. T., Schilling, W. A., and Wheeler, K. T. Cellular radiosensitivity of a rat brain tumor. Cancer, 35:1545-1550, 1975.
11. Wallen, C. A., Michaelson, S. M., and Wheeler, K. T. Evidence for an unconventional radiosensitivity of rat 9L subcutaneous tumors. Radiat. Res., 85:529-541, 1980.
12. Howell, R. L., and Koch, C. J. The disaggregation, separation and identification of cells from irradiated and unirradiated EMT6 mouse tumors. Int. J. Radiat. Oncol. Biol. Phys., (6:311-318, 1980.
13. Evans, S. M., and Koch, C. J. Characterization of the 9L glioma as a tissue isolated epigastric implant. Radiat. Oncol. Invest., 2:134-143, 1994.
14. Lord, E. M., Harwell, L., and Koch, C. J. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. Cancer Res., 53:5271-5276, 1993.
15. Southwick, P. L., Ernst, L. A., Tauriello, E. W., Parker, S. R., Mujumdar, R. B., Mujumbdar, S. R., Clever, H. A., and Waggoner, A. S. Cyanine dye labeling reagents - carboxymethylindocyanine succinimidyl esters. Cytometry, 11:418-430, 1990.
16. Laughlin, K. M., Evans, S. M., Lord, E. M., and Koch, C. J. Biodistribution of EF5 [2-(2-nitro-iH-imidazole-lyl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide] in BALB/c mice bearing EMT6tumors; implications for oxygen measurements in normal and tumor tissues. Journal of Pharmacology and Experimental Therapeutics, 277: 1049-1057, 1996.
17. Koch, C. J., Giandomenico, A. R., and Lee lyengar, C. W. Bioreductive metabolism of AF-2 [2(2-furyl)-3(5-nitro-2-furyl)acrylamide] combined with 2-nitroimidazole radiosensitizing agents. Biochem. Pharmacol., 46:1029-1036, 1993.
18. Evans S.M., Jenkins W.T., Joiner B., Lord E.M. and Koch C.J. 2-nitroimidazole (EF5) binding predicts radiation resistance in individual 9L subcutaneous tumors Cancer Res., 56: 405-411, 1996.
19. Moulder, J. E., and Rockwell, S. Tumor hypoxia: its impact on cancer therapy. Cancer and Metastasis Rev., 5:313-341, 1987.
20. Moulder, J. E., and Martin, D. F. Hypoxic fraction determinations in the BA1112 rat sarcoma: variations within and among assay techniques. Rad. Res., 99, 1984.
21. Tannock, I. F. Oxygen diffusion and the distribution of radiosensitivity in tumours. Br. J. Radiol., 45:515-524, 1972.
22. Lartigau, E., Lusinchi, A., Randrianarivelo, H., Weeger, P., Wibault, P., Luboinski, B., Eschwege, E., and Guichard, M. Oxygen tension distribution before and during accelerated radiotherapy and carbogen breathing: preliminary results, pp. 305-312 In: Tumor Oxygenation. Eds. Vaupel, Kelleher, Gunderoth. Gustav Fischer Verlag, Stuttgart, 1995.
23. Lawrence, V., Ward, R., and Bleenen, N. Tumor pO2 distribution in patients treated with the combination of nicotinamide and carbogen breathing. In: Tumor Oxygenation. Eds. Vaupel, Kelleher, Gunderoth. Gustav Fischer Verlag, Stuttgart, 1995.
24. Biade, S., Yeh, K. A., Milito, S. J., Brown, D. Q., Lanciano, R. M., and Chapman, J. D. Electrode measurements of oxygen tensions in rat prostate carcinomas and comparisons with other assays, pp. 83-94. In: Tumor Oxygenation. Eds. Vaupel, Kelleher, Gunderoth. Gustav Fischer Verlag, Stuttgart, 1995.